Generics poured out before ‘ezetimibe’ patent expiration of KRW 60 billion
Facing the patent expiration of the ezetimibe drug(product name: Ezetrol), a hyperlipidemia treatment, a number of ezetimibe+statin complexes emerged and foretold fierce competition.
The substance patent expiration of the ezetimibe drug is the 29th of April. The most well-known drug, Vytorin, a ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
